Dangerous Drugs - Campath

Manufactured by Schering and Genzyme Corporation, Campath is used for the treatment of Leukemia. After a clinical trial concluded in September of 2005, the FDA suspended dosages of Campath after three cases of serious side effects came to light, including Idiopathic Thrombocytopenic Purpura or ITP.

ITP is a condition which causes a low platelet count, resulting in abnormal bleeding. The makers of Campath notified regulatory authorities, trial sites and existing patients regarding the risks of using the drug. The company has since consulted industry experts and medical professionals on ways to reduce the risk of ITP occurrence among users of Campath.

If you or a loved one has suffered an injury, illness or death, that seems to have been someone else’s fault, call VanDerGinst Law at 1-866-843-7367 or click here for a FREE online case evaluation. The initial consultation is free of charge. If we agree to handle your injury case, we will work on a contingency fee basis, which means we get paid for our services only if, and when, there is a money recovery for you. In many cases a lawsuit must be filed before an applicable expiration date, known as a statute of limitations. So please call right away to ensure that you do not waive your right to possible compensation.